CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ensemble Discovery Corporation, a biotechnology company developing novel classes of therapeutics and diagnostics using its proprietary DNA Programmed Chemistry™ (DPC™) platform, today announced the appointment of Francis Barany, Ph.D., Simon Campbell CBE, FMedSci, FRS, Gerard Evan, Ph.D., FRS, and Mark Murcko, Ph.D. to its Scientific Advisory Board.
